The DOI matches its Crossref record.
The United States Pharmacopeia/National Formulary: Its History, Organization, and Role in Harmonization
Abstract
The assessment of “bioequivalence” (BE) refers to a procedure that compares the bioavailability of a drug from different formulations. Bioavailability is defined as the rate and extent to which the active ingredient or active moiety is absorbed from a drug product. For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action. In this chapter, we will not present methods for drugs that are not absorbed into the bloodstream (or absorbed so little as to be unmeasurable) or where the concentration-time profile of the drug in the bloodstream is not considered to reflect the rate and extent of the drug at the site of action (e.g., topically active products). However, statistical methodology for these drugs, in general, will be approached in a manner consistent with methods presented for drugs that are absorbed and where that absorption is meaningful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Patel, V. R., & Amiji, M. M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016054306763 · Cited by 397
Tablet Splitting and Weight Uniformity of Half-Tablets of 4 Medications in Pharmacy Practice
Tahaineh, L. M., & Gharaibeh, S. F. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012442716 · Cited by 54
Akhgari, A., & Tavakol, A. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.030 · Cited by 22
Metadata
- Authors
- Brown, W., & Marques, M.
- Venue
- Drugs and the Pharmaceutical Sciences
- Publisher
- CRC Press
- Published
- 2013-09-26
- Pages
- 319-332
- ISSN
- 0360-2583 (ISSN-L)
- 2154-5219
- OpenAlex
- W2502777841
- Cited by
- 207
- References
- 0
- FWCI
- 34.61
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.